Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer.
| Autor: | Bendell JC, Nemunaitis J, Vukelja SJ, Hagenstad C, Campos LT, Hermann RC, Sportelli P, Gardner L, Richards DA |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 11/20/2011, Vol. 29 Issue 33, p4394-4400, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|